These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 20693979

  • 1. ETS family-associated gene fusions in Japanese prostate cancer: analysis of 194 radical prostatectomy samples.
    Miyagi Y, Sasaki T, Fujinami K, Sano J, Senga Y, Miura T, Kameda Y, Sakuma Y, Nakamura Y, Harada M, Tsuchiya E.
    Mod Pathol; 2010 Nov; 23(11):1492-8. PubMed ID: 20693979
    [Abstract] [Full Text] [Related]

  • 2. Gene fusions between TMPRSS2 and ETS family genes in prostate cancer: frequency and transcript variant analysis by RT-PCR and FISH on paraffin-embedded tissues.
    Tu JJ, Rohan S, Kao J, Kitabayashi N, Mathew S, Chen YT.
    Mod Pathol; 2007 Sep; 20(9):921-8. PubMed ID: 17632455
    [Abstract] [Full Text] [Related]

  • 3. TMPRSS2:ETS fusions and clinicopathologic characteristics of prostate cancer patients from Eastern China.
    Dong J, Xiao L, Sheng L, Xu J, Sun ZQ.
    Asian Pac J Cancer Prev; 2014 Sep; 15(7):3099-103. PubMed ID: 24815454
    [Abstract] [Full Text] [Related]

  • 4. Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohort.
    Esgueva R, Perner S, J LaFargue C, Scheble V, Stephan C, Lein M, Fritzsche FR, Dietel M, Kristiansen G, Rubin MA.
    Mod Pathol; 2010 Apr; 23(4):539-46. PubMed ID: 20118910
    [Abstract] [Full Text] [Related]

  • 5. Molecular genetic analyses of the TMPRSS2-ERG and TMPRSS2-ETV1 gene fusions in 50 cases of prostate cancer.
    Winnes M, Lissbrant E, Damber JE, Stenman G.
    Oncol Rep; 2007 May; 17(5):1033-6. PubMed ID: 17390040
    [Abstract] [Full Text] [Related]

  • 6. Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer.
    Laxman B, Tomlins SA, Mehra R, Morris DS, Wang L, Helgeson BE, Shah RB, Rubin MA, Wei JT, Chinnaiyan AM.
    Neoplasia; 2006 Oct; 8(10):885-8. PubMed ID: 17059688
    [Abstract] [Full Text] [Related]

  • 7. [Frequency and transcript variant analysis of gene fusions between TMPRSS2 and ETS transcription factor genes in prostate cancer].
    Dai MJ, Chen LL, Zheng YB, Chen W, Tao ZH, Weng ZL, Wu XL, Li CD, Chen ZG, Chen XD, Shi SB.
    Zhonghua Yi Xue Za Zhi; 2008 Mar 11; 88(10):669-73. PubMed ID: 18642766
    [Abstract] [Full Text] [Related]

  • 8. TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer.
    Hermans KG, van Marion R, van Dekken H, Jenster G, van Weerden WM, Trapman J.
    Cancer Res; 2006 Nov 15; 66(22):10658-63. PubMed ID: 17108102
    [Abstract] [Full Text] [Related]

  • 9. TMPRSS2:ERG fusion gene occurs less frequently in Chinese patients with prostate cancer.
    Jiang H, Mao X, Huang X, Zhao J, Wang L, Xu J, Zhang H, Lu Y, Yu Y.
    Tumour Biol; 2016 Sep 15; 37(9):12397-12402. PubMed ID: 27320318
    [Abstract] [Full Text] [Related]

  • 10. ERG rearrangement is present in a subset of transition zone prostatic tumors.
    Falzarano SM, Navas M, Simmerman K, Klein EA, Rubin MA, Zhou M, Magi-Galluzzi C.
    Mod Pathol; 2010 Nov 15; 23(11):1499-506. PubMed ID: 20693982
    [Abstract] [Full Text] [Related]

  • 11. Retention of Interstitial Genes between TMPRSS2 and ERG Is Associated with Low-Risk Prostate Cancer.
    Murphy SJ, Kosari F, Karnes RJ, Nasir A, Johnson SH, Gaitatzes AG, Smadbeck JB, Rangel LJ, Vasmatzis G, Cheville JC.
    Cancer Res; 2017 Nov 15; 77(22):6157-6167. PubMed ID: 29127096
    [Abstract] [Full Text] [Related]

  • 12. Clinical implications of TMPRSS2-ERG gene fusion expression in patients with prostate cancer treated with radical prostatectomy.
    Rubio-Briones J, Fernández-Serra A, Calatrava A, García-Casado Z, Rubio L, Bonillo MA, Iborra I, Solsona E, López-Guerrero JA.
    J Urol; 2010 May 15; 183(5):2054-61. PubMed ID: 20303538
    [Abstract] [Full Text] [Related]

  • 13. Characterization of ETS gene aberrations in select histologic variants of prostate carcinoma.
    Han B, Mehra R, Suleman K, Tomlins SA, Wang L, Singhal N, Linetzky KA, Palanisamy N, Zhou M, Chinnaiyan AM, Shah RB.
    Mod Pathol; 2009 Sep 15; 22(9):1176-85. PubMed ID: 19465903
    [Abstract] [Full Text] [Related]

  • 14. Prognostic Significance of TMPRSS2-ERG Fusion Gene in Prostate Cancer.
    Kulda V, Topolcan O, Kucera R, Kripnerova M, Srbecka K, Hora M, Hes O, Klecka J, Babuska V, Rousarova M, Benson V, Pesta M.
    Anticancer Res; 2016 Sep 15; 36(9):4787-93. PubMed ID: 27630329
    [Abstract] [Full Text] [Related]

  • 15. SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer.
    Rickman DS, Pflueger D, Moss B, VanDoren VE, Chen CX, de la Taille A, Kuefer R, Tewari AK, Setlur SR, Demichelis F, Rubin MA.
    Cancer Res; 2009 Apr 01; 69(7):2734-8. PubMed ID: 19293179
    [Abstract] [Full Text] [Related]

  • 16. Novel 5' fusion partners of ETV1 and ETV4 in prostate cancer.
    Barros-Silva JD, Paulo P, Bakken AC, Cerveira N, Løvf M, Henrique R, Jerónimo C, Lothe RA, Skotheim RI, Teixeira MR.
    Neoplasia; 2013 Jul 01; 15(7):720-6. PubMed ID: 23814484
    [Abstract] [Full Text] [Related]

  • 17. Androgen regulation of ETS gene fusion transcripts in prostate cancer.
    Gasi D, Trapman J.
    Methods Mol Biol; 2011 Jul 01; 776():335-48. PubMed ID: 21796535
    [Abstract] [Full Text] [Related]

  • 18. TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming.
    Iljin K, Wolf M, Edgren H, Gupta S, Kilpinen S, Skotheim RI, Peltola M, Smit F, Verhaegh G, Schalken J, Nees M, Kallioniemi O.
    Cancer Res; 2006 Nov 01; 66(21):10242-6. PubMed ID: 17079440
    [Abstract] [Full Text] [Related]

  • 19. Clonal evaluation of early onset prostate cancer by expression profiling of ERG, SPINK1, ETV1, and ETV4 on whole-mount radical prostatectomy tissue.
    Lu Z, Williamson SR, Carskadon S, Arachchige PD, Dhamdhere G, Schultz DS, Stricker H, Peabody JO, Jeong W, Chitale DA, Bismar TA, Rogers CG, Menon M, Gupta NS, Palanisamy N.
    Prostate; 2020 Jan 01; 80(1):38-50. PubMed ID: 31584209
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States.
    Mosquera JM, Mehra R, Regan MM, Perner S, Genega EM, Bueti G, Shah RB, Gaston S, Tomlins SA, Wei JT, Kearney MC, Johnson LA, Tang JM, Chinnaiyan AM, Rubin MA, Sanda MG.
    Clin Cancer Res; 2009 Jul 15; 15(14):4706-11. PubMed ID: 19584163
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.